News

“djuvant chemoradiation combined with camrelizumab was well tolerated and yielded significantly improved long-term survival,” the researchers wrote.
In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...
Olaparib demonstrated activity in a phase 2 trial of patients who had advanced biliary tract cancer with homologous recombination repair (HRR) mutations. Results from this trial were presented at the ...
FDA designates FF-10832 as an orphan drug for biliary tract cancer, promising enhanced treatment options for this aggressive ...
The European Commission (EC) has granted conditional approval to Jazz Pharmaceuticals’ Ziihera (zanidatamab) to treat a ...
Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the best high short interest stocks with huge upside potential. On July 2, Jazz ...
Read full-text medical journal articles from Medscape's Gallbladder and Biliary Tract Disease News.
In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...
US biotech Jazz Pharmaceuticals yesterday announced that the European Commission (EC) has granted conditional marketing ...
Fujifilm Pharma’s liposomal formulation of gemcitabine FF-10832 receives US FDA’s orphan drug designation to treat biliary tract cancer: Cambridge, Massachusetts Wednesday, Ju ...
In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an immunotherapy drug) plus gemcitabine and cisplatin (GemCis, chemotherapy drugs) as the ...
FUJIFILM Pharmaceuticals U.S.A., Inc., drug development center and a leading provider of Contract Development and Manufacturing Organization (CDMO) services for drug delivery system (DDS) technologies ...